January 17, 2020
12:10 pm

Most EVALI Patients Used THC-Containing Products as New Cases Continue To Decline

CDC today released two reports on e-cigarette, or vaping, product use-associated lung injury (EVALI), confirming that most EVALI patients report using tetrahydrocannabinol (THC)-containing products and that new EVALI cases have continued to decline with time.


This article originally appeared here: https://tools.cdc.gov/api/embed/downloader/download.asp?m=132608&c=403179. The source website for this article is CDC Newsroom Feed.
The original publication date for this article is January 17, 2020 6:10 pm

In the Event of Real Emergency or Disaster Events, Contact CDPH PHEOC.
P: 312-742-7921